Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation.

Mackin SR, Liang C-Y, Karl CE, Kleverov M, Khan MZ, Selvam T, Mack M, Alter G, Guarino B, Corti D, Schmid MA, Diamond MS

Open source

DOI: 10.1128/mbio.00557-26
Published: 2026 May 13
Container: mBio
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1128/mbio.00557-26,
  title = {Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation.},
  author = {Mackin SR and Liang C-Y and Karl CE and Kleverov M and Khan MZ and Selvam T and Mack M and Alter G and Guarino B and Corti D and Schmid MA and Diamond MS},
  year = {2026},
  journal = {mBio},
  doi = {10.1128/mbio.00557-26},
  url = {https://doi.org/10.1128/mbio.00557-26}
}

RIS

TY  - JOUR
TI  - Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation.
AU  - Mackin SR
AU  - Liang C-Y
AU  - Karl CE
AU  - Kleverov M
AU  - Khan MZ
AU  - Selvam T
AU  - Mack M
AU  - Alter G
AU  - Guarino B
AU  - Corti D
AU  - Schmid MA
AU  - Diamond MS
PY  - 2026
JO  - mBio
DO  - 10.1128/mbio.00557-26
UR  - https://doi.org/10.1128/mbio.00557-26
ER  -

APA

SR, M., C-Y, L., CE, K., M, K., MZ, K., T, S., M, M., G, A., B, G., D, C., MA, S., & MS, D. (2026). Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation.. mBio. https://doi.org/10.1128/mbio.00557-26

Source records

pubmed · retrieved 2026-09-27T16:47:03.198Z